Kenneth Aldape joined the NCI Center for Cancer Research as chief of the Laboratory of Pathology.
Carol Aghajanian, MD of Memorial Sloan Kettering Cancer Center, was named chair of NRG Oncology's Gynecologic Cancer Committee.
Matthew Hudson was appointed co-chair of the NRG Oncology Cancer Care Delivery Research Committee.
Cancer Today, a quarterly magazine published by the American Association for Cancer Research has launched a new website, which is aimed at helping public find late-breaking news about cancer research, new cancer therapies, prevention strategies, and clinical trials.
NCI may need to invest at least $125 million in new money in the Research Project Grant pool in 2018 if the institute plans on keeping the success rates for R01s comparable to 2017, said NCI Director Ned Sharpless.
What a difference a week makes.
A group of tobacco control advocates, one of whom receives money from Philip Morris International, issued a press release trumpeting that “E-Cigarettes are Saving Lives,” and attributed this conclusion to a recent report by the National Academy of Sciences, Engineering, and Medicine.
Cancer Research UK has shortlisted ten multidisciplinary, international teams for what amounts to the second leg of competition for Grand Challenge awards.
FDA approved abiraterone acetate (Zytiga) tablets in combination with prednisone for metastatic high-risk castration-sensitive prostate cancer (CSPC). The drug is sponsored by Janssen Biotech Inc.
Foundation Medicine Inc. and the European Organisation for Research and Treatment of Cancer announced a collaboration in which Foundation Medicine's comprehensive genomic profiling tests will be used to inform patient eligibility for oncology clinical trials through the EORTC's Screening Patients for Efficient Clinical Trial Access program, which is a pan-European network built by the EORTC with key institutions collaborating to provide efficient access for patients to molecularly driven clinical trials.
